impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase
Nobecourt, E, Davies, M. J, Brown, B. E, Curtiss, L. K, Bonnet, D. J, Charlton, F, Januszewski, A. S, Jenkins, A. J, Barter, P. J, Rye, K.-A
Published in Diabetologia (01.03.2007)
Published in Diabetologia (01.03.2007)
Get full text
Journal Article
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study
Dalton, William S., Crowley, John J., Salmon, Sydney S., Grogan, Thomas M., Laufman, Leslie Rodgers, Weiss, Geoffrey R., Bonnet, John D.
Published in Cancer (01.02.1995)
Published in Cancer (01.02.1995)
Get full text
Journal Article
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study
Zalupski, M, Metch, B, Balcerzak, S, Fletcher, W S, Chapman, R, Bonnet, J D, Weiss, G R, Ryan, J, Benjamin, R S, Baker, L H
Published in JNCI : Journal of the National Cancer Institute (03.07.1991)
Published in JNCI : Journal of the National Cancer Institute (03.07.1991)
Get more information
Journal Article
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience
Hersh, E M, Metch, B S, Muggia, F M, Brown, T D, Whitehead, R P, Budd, G T, Rinehart, J J, Crawford, E D, Bonnet, J D, Behrens, B C
Published in Journal of immunotherapy (01.12.1991)
Published in Journal of immunotherapy (01.12.1991)
Get more information
Journal Article
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study
Salmon, S E, Tesh, D, Crowley, J, Saeed, S, Finley, P, Milder, M S, Hutchins, L F, Coltman, Jr, C A, Bonnet, J D, Cheson, B
Published in Journal of clinical oncology (01.09.1990)
Published in Journal of clinical oncology (01.09.1990)
Get more information
Journal Article
Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group study
Gupta, V, Thompson, E B, Stock-Novack, D, Salmon, S E, Pierce, H I, Bonnet, J D, Chilton, D, Beckford, J
Published in Investigational new drugs (01.01.1994)
Published in Investigational new drugs (01.01.1994)
Get more information
Journal Article
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study
Kraut, E H, Crowley, J J, Grever, M R, Keppen, M D, Bonnet, J D, Hynes, H E, Salmon, S E
Published in Investigational new drugs (01.05.1990)
Published in Investigational new drugs (01.05.1990)
Get more information
Journal Article
Randomized trial of 5‐fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest oncology group study
Bukowski, Ronald M., Balcerzak, Stanley P., O'Bryan, Robert M., Bonnet, John D., Chen, T. Timothy
Published in Cancer (01.11.1983)
Published in Cancer (01.11.1983)
Get full text
Journal Article
Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study
Hoogstraten, B., George, S. L., Samal, B., Rivkin, S. E., Costanzi, J. J., Bonnet, J. D., Thigpen, T., Braine, H.
Published in Cancer (01.07.1976)
Published in Cancer (01.07.1976)
Get full text
Journal Article
Evaluation of amonafide in refractory and relapsing multiple myeloma: a Southwest Oncology Group study
Hanson, K H, Crowley, J, Salmon, S E, Keppen, M, Braun, T J, Bonnet, J D
Published in Anti-cancer drugs (01.06.1991)
Published in Anti-cancer drugs (01.06.1991)
Get more information
Journal Article
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study
Durie, B G, Crowley, J, Coltman, Jr, C A, Chapman, R A, Balcerzk, S P, Bonnet, J D, Lipschitz, D A, Stephens, R L, Cheson, B D
Published in Investigational new drugs (01.11.1991)
Published in Investigational new drugs (01.11.1991)
Get more information
Journal Article
A useful high‐dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas
Saiki, John H., Baker, Laurence H., Rivkin, Saul E., Shahbender, Salah, Fletcher, William S., Athens, John W., Balcerzak, Stanley P., Bonnet, John D.
Published in Cancer (15.11.1986)
Published in Cancer (15.11.1986)
Get full text
Journal Article
A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group study
Edelstein, M B, Crowley, J J, Valeriote, F A, Bonnet, J D, Carden, J O, Khanna, R C, Salmon, S E, Ungerleider, J S
Published in Investigational new drugs (01.01.1990)
Published in Investigational new drugs (01.01.1990)
Get more information
Journal Article
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group study
Gagliano, R, Levin, H, El-Bolkainy, M N, Wilson, H E, Stephens, R L, Fletcher, W S, Rivkin, S E, O'Bryan, R M, Coltman, Jr, C A, Saiki, J H, Stuckey, W J, Balducci, L, Bonnet, J D, Dixon, D O
Published in American journal of clinical oncology (01.04.1983)
Published in American journal of clinical oncology (01.04.1983)
Get more information
Journal Article